Clinical characteristics and risk profile of patients with elevated baseline serum tryptase

Allergologia et Immunopathologia

Volumn 42, Issue 6, 2014, Pages 544-552

  Fellinger, C ^a   Hemmer, W ^a   Wohrl S ^a   Sesztak Greinecker, G ^a   Jarisch, R ^a   Wantke, F ^a  

^a FAZ Floridsdorf Allergy Centre   (Austria)

Author keywords

Anaphylaxis; Basal serum tryptase; Mast cell activation syndrome; Mastocytosis

Indexed keywords

CONTRAST MEDIUM; TRYPTASE; VENOM;

ADOLESCENT; ADULT; AGED; ALLERGY; ANAPHYLAXIS; ARTICLE; BONE PAIN; CELL ACTIVATION; CHILD; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; EDEMA; ELEVATED BASAL SERUM TRYPTASE; FATIGUE; FEMALE; FLUSHING; FOOD; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; INFANT; INSECT STING; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL ACTIVATION SYNDROME; MASTOCYTOSIS; METEORISM; MYALGIA; OUTPATIENT DEPARTMENT; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; URTICARIA; VERTIGO; VERY ELDERLY;

EID: 84925943616     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2014.05.002     Document Type: Article

References (27)

1. Alvarez-Twose I. Bonadonna P. Matito A. Zanotti R. González-de-Olano D. Sánchez-Muñoz L. et al. Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis. J Allergy Clin Immunol 2013, 131:614-615.
2. Bonadonna P. Zanotti R. Pagani M. Caruso B. Perbellini O. Colarossi S. et al. How much specific is the association between hymenoptera venom allergy and mastocytosis. Allergy 2009, 64:1379-1382.
3. Przybilla B. Ruëff F. Hymenoptera venom allergy. JDDG 2010, 8:114-129.
4. Brockow K. Jofer C. Behrendt H. Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008, 63:226-232.
5. Worm M. Babina M. Hompes S. Causes and risk factors for anaphylaxis. J Dtsch Dermatol Ges 2013, 11:44-50.
6. Gotlib J. Pardanani A. Akin C. Reiter A. George T. Hermine O. et al. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood 2013, 121:2393-2401.
7. Ruëff F. Przybilla B. Bilo M.B. Müller U. Scheipl F. Aberer W. et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase. J Allergy Clin Immunol 2009, 124:1047-1054.
8. Valent P. Akin C. Arock M. Brockow K. Butterfield J.H. Carter M.C. et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2012, 157:215-225.
9. Valent P. Mast cell activation syndromes: definition and classification. Allergy 2013, 68:417-424.
10. Schwartz L.B. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin N Am 2006, 26:451-463.
11. Ring J. Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977, 1:466-469.
12. Alvarez-Twose I. González de Olano D. Sánchez-Muñoz L. Matito A. Esteban-López M.I. Vega A. et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 2010, 125:1269-1278.
13. Worm M. Epidemiology of anaphylaxis. Hautarzt 2013, 64:88-92.
14. Sahiner U.M. Yavuz S.T. Buyuktiryaki B. Cavkaytar O. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy 2014, 69:265-268.
15. Panesar S.S. Javad S. De Silva D. Nwaru B.I. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013, 68:1353-1361.
16. Gelincik A. Demirtürk M. Yilmaz E. Ertek B. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol 2013, 110:96-100.
17. Schliemann S. Seyfarth F. Hipler U.C. Elsner P. Impact of age and heterophilic interference on the basal serum tryptase, a risk indication for anaphylaxis, in 1,092 dermatology patients. Acta Derm Venereol 2012, 92:484-489.
18. Theoharides T.C. Papaliodis D. Tagen M. Konstantinidou A. Kempuraj D. Clemons A. Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol 2005, 25:515-520.
19. Amon U. Hartmann K. Horny H.P. Nowak A. Mastocytosis - an update. J Dtsch Dermatol Ges 2010, 8:695-711.
20. Cardet J.C. Castells M.C. Hamilton M.J. Immunology and clinical manifestations of non-clonal mast cell activation syndrome. Curr Allergy Asthma Rep 2013, 13:10-18.
21. Niedoszytko M. de Monchy J. van Doormaal J.J. Jassem E. Oude Elberink J.N.G. Mastcytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy 2009, 64:1237-1245.
22. Bonadonna P. Perbellini O. Passalacqua G. Caruso B. Colarossi S. Dal Fior D. et al. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009, 123:680-686.
23. Valent P. Aberer E. Beham-Schmid C. Fellinger C. Fuchs W. Gleixner K.V. et al. Practical guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the austrian competence network on mastocytosis. Am J Blood Res 2013, 3:174-180.
24. Sala-Cunill A. Cardona V. Labrador-Horrillo M. Luengo O. Esteso O. Garriga T. et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013, 160:192-199.
25. Haeberli G. Brönnimann M. Hunziker T. Müller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003, 33:1216-1220.
26. Ruëff F. Przybilla B. Biló M.B. Müller U. Scheipl F. Aberer W. et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol 2010, 126:105-111.
27. Asero R. Farioli L. Pastorello E.A. Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship. Int Arch Allergy Immunol 2012, 158:276-280.